Jim Simons Yumanity Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.5 - $1.87 $2,679 - $3,339	-1,786 Reduced 2.53%	68,722 $108,000
Q2 2022 Aug 12, 2022	BUY	$1.02 - $1.99 $10,302 - $20,099	10,100 Added 16.72%	70,508 $128,000
Q1 2022 May 13, 2022	SELL	$0.97 - $3.27 $35,028 - $118,086	-36,112 Reduced 37.41%	60,408 $91,000
Q4 2021 Feb 11, 2022	BUY	$2.81 - $10.48 $170,288 - $635,098	60,601 Added 168.72%	96,520 $286,000
Q3 2021 Nov 12, 2021	BUY	$8.3 - $12.04 $298,127 - $432,464	35,919 New	35,919 $371,000

Q1 2021 May 13, 2021	SELL	$16.69 - $22.52 $306,244 - $413,219	-18,349 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$16.67 - $25.4 $305,877 - $466,064	18,349 New	18,349 $312,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.